Latest GMOs Publications
Summary Notification Information Format (SNIF) AdCh3NSmut1
Year: 2014
Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine AdCh3NSmut1
Environmental Risk Assessment for MVA-NSmut
Year: 2014
Environmental Risk Assessment for Modified recombinant virus vaccine MVA-NSmut
How to make a Representation
Year: 2014
How to make a Representation to the EPA regarding Deliberate Release G0536-01
Summary Notification Information Format (SNIF) for MVA-NSmut
Year: 2014
Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine MVA-NSmut
G0536-01 Consent Conditions
Year: 2014
G0536-01 Consent Conditions issued to The GUIDE Department, St. James's Hospital, Dublin on 22 July 2014 for a clinical trial using a Genetically Modified Organism (GMO)
Environmental Risk Assessment for MVA-NSmut
Year: 2014
Environmental Risk Assessment for Modified recombinant virus vaccine MVA-NSmut
Environmental Risk Assessment for AdCh3NSmut1
Year: 2014
Environmental Risk Assessment for Modified recombinant virus vaccine AdCh3NSmut1
How to make a Representation
Year: 2014
How to make a Representation to the EPA regarding Deliberate Release G0536-01
Summary Notification Information Format (SNIF) for MVA-NSmut
Year: 2014
Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine MVA-NSmut
Summary Notification Information Format (SNIF) AdCh3NSmut1
Year: 2014
Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine AdCh3NSmut1
Intervet Letter of 10 March 2014 re cessation of trial
Year: 2014
Correspondence received from Intervet International B.V. on 10 March 2014 to advise the Agency of their decision to stop the veterinary trial
G0493-01 Inspector's Report to the Board of the Agency
Year: 2013
All documentation submitted in respect of this notification, including valid representations made by members of the public, was taken into consideration by the EPA Inspector in her report to the Board of the Agency.
Inspector's Memo to Board for approval to modify condition
Year: 2013
Inspector's Memo to Board for approval to modify condition
Letter from EPA to Intervet International BV with modified condition
Year: 2013
Letter from EPA to Intervet International BV, dated 11 June 2013, with modified condition
How to make a representation for G0493-01
Year: 2013
How to make a representation to the EPA about the proposed Deliberate Release G0493
Board Minute Extract re decision on modified condition
Year: 2013
An extract from the Board Minute of the meeting of 10 June 2013,approving the modification of Condition 6.8
G0493-01 Valid representations received from members of the public
Representations received from members of the public in response to Intervet International BV's notification, June 2013
Year: 2013
The following valid representations were submitted in response to the notification by Intervet International BV, seeking consent to carry out a veterinary trial using a genetically modified vaccine
Non-confidential Annex List G0493
Year: 2013
List of non-confidential annexes received as part of Merck Sharp and Dohme/Intervet International BV's application G0493
G0493-01 Consent Conditions
Year: 2013
G0493-01 Consent Conditions issued to Intervet International BV on 10 April 2013 for veterinary trial using a genetically modified vaccine